Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - alanine 14 g/l;  ;  ; arginine 12 g/l;  ;  ; glycine 11 g/l;  ;  ;  ; histidine 3 g/l;  ;  ;  ; isoleucine 5 g/l;  ;  ;  ; leucine 7.4 g/l;  ;  ;  ;  ; lysine acetate 9.3 g/l equivalent to l-lysine 6.6 g;  ;  ; methionine 4.3 g/l;  ;  ; phenylalanine 5.1 g/l;  ;  ; proline 11.2 g/l;  ; serine 6.5 g/l;  ;  ;  ; taurine 1 g/l;  ; threonine 4.4 g/l;  ;  ;  ; tryptophan 2 g/l;  ;  ; tyrosine 0.4 g/l;  ; valine 6.2 g/l;  ;  ;  ;  ; glucose monohydrate 462 g/l equivalent to glucose (anhydrous) 420 g/l;  ;  ; fish oil 30 g/l; medium-chain triglycerides 60 g/l;  ; olive oil 50 g/l;  ; soya oil 60 g/l;   - emulsion for infusion - active: alanine 14 g/l     arginine 12 g/l     glycine 11 g/l       histidine 3 g/l       isoleucine 5 g/l       leucine 7.4 g/l         lysine acetate 9.3 g/l equivalent to l-lysine 6.6 g     methionine 4.3 g/l     phenylalanine 5.1 g/l     proline 11.2 g/l   serine 6.5 g/l       taurine 1 g/l   threonine 4.4 g/l       tryptophan 2 g/l     tyrosine 0.4 g/l   valine 6.2 g/l         excipient: glacial acetic acid nitrogen water for injection active: glucose monohydrate 462 g/l equivalent to glucose (anhydrous) 420 g/l     excipient: hydrochloric acid nitrogen water for injection active: fish oil 30 g/l medium-chain triglycerides 60 g/l   olive oil 50 g/l   soya oil 60 g/l   excipient: dl-alpha tocopherol egg lecithin glycerol nitrogen sodium hydroxide sodium oleate water for injection - parenteral nutrition for adults and children aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - alanine 12 g/l;  ;  ;  ; arginine 8.4 g/l (l-arginine);  ;  ; aspartic acid 2.5 g/l (l-aspartic acid);  ;  ; calcium gluconate monohydrate 2.24 g/l;  ; cysteine 0.42 g/l (as l-cysteine hydrochloride); glutamic acid 4.2 g/l (l-glutamic acid);  ;  ; glycine 5.9 g/l (as aminoacetic acid);  ;  ; histidine 5.1 g/l (l-histidine);  ;  ; isoleucine 4.2 g/l (l-isoleucine);  ;  ;  ; leucine 5.9 g/l (l-leucine);  ;  ;  ; lysine hydrochloride 6.8 g/l;  ;  ;  ; magnesium sulfate heptahydrate 1.97 g/l; methionine 4.2 g/l (l-methionine);  ;  ; phenylalanine 5.9 g/l (l-phenylalanine);  ;  ;  ; potassium chloride 3.73 g/l; proline 5.1 g/l (l-proline);  ; serine 3.4 g/l (l-serine);  ;  ;  ;  ; sodium acetate trihydrate 13.6 g/l;  ;  ; threonine 4.2 g/l (l-threonine);  ;  ;  ; tryptophan 1.4 g/l (l-tryptophan);  ; tyrosine 0.17 g/l (l-tyrosine); valine 5.5 g/l (l-valine);  ;   - solution for infusion - active: alanine 12 g/l       arginine 8.4 g/l (l-arginine)     aspartic acid 2.5 g/l (l-aspartic acid)     calcium gluconate monohydrate 2.24 g/l   cysteine 0.42 g/l (as l-cysteine hydrochloride) glutamic acid 4.2 g/l (l-glutamic acid)     glycine 5.9 g/l (as aminoacetic acid)     histidine 5.1 g/l (l-histidine)     isoleucine 4.2 g/l (l-isoleucine)       leucine 5.9 g/l (l-leucine)       lysine hydrochloride 6.8 g/l       magnesium sulfate heptahydrate 1.97 g/l methionine 4.2 g/l (l-methionine)     phenylalanine 5.9 g/l (l-phenylalanine)       potassium chloride 3.73 g/l proline 5.1 g/l (l-proline)   serine 3.4 g/l (l-serine)         sodium acetate trihydrate 13.6 g/l     threonine 4.2 g/l (l-threonine)       tryptophan 1.4 g/l (l-tryptophan)   tyrosine 0.17 g/l (l-tyrosine) valine 5.5 g/l (l-valine)     excipient: glacial acetic acid water for injection - intravenous supply of amino acids to patients with moderately increased requirements who are unable to receive sufficient amounts of protein enterally

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - alanine 12 g/l;  ;  ;  ; arginine 8.4 g/l (l-arginine);  ;  ; aspartic acid 2.5 g/l (l-aspartic acid);  ;  ; cysteine 0.42 g/l (l-cysteine); glutamic acid 4.2 g/l (l-glutamic acid);  ;  ; glycine 5.9 g/l (as aminoacetic acid);  ;  ;  ; histidine 5.1 g/l (l-histidine);  ;  ;  ; isoleucine 4.2 g/l (l-isoleucine);  ;  ;  ; leucine 5.9 g/l (l-leucine);  ;  ;  ; lysine acetate 6.8 g/l equivalent to -lysine 6.8 g/l;  ;  ; methionine 4.2 g/l (l-methionine);  ;  ; phenylalanine 5.9 g/l (l-phenylalanine);  ;  ;  ; proline 5.1 g/l (l-proline);  ; serine 3.4 g/l (l-serine);  ;  ;  ;  ; threonine 4.2 g/l (l-threonine);  ;  ;  ; tryptophan 1.4 g/l (l-tryptophan);  ; tyrosine 0.17 g/l (l-tyrosine); valine 5.5 g/l (l-valine);  ;  ;   - solution for infusion - active: alanine 12 g/l       arginine 8.4 g/l (l-arginine)     aspartic acid 2.5 g/l (l-aspartic acid)     cysteine 0.42 g/l (l-cysteine) glutamic acid 4.2 g/l (l-glutamic acid)     glycine 5.9 g/l (as aminoacetic acid)       histidine 5.1 g/l (l-histidine)       isoleucine 4.2 g/l (l-isoleucine)       leucine 5.9 g/l (l-leucine)       lysine acetate 6.8 g/l equivalent to -lysine 6.8 g/l     methionine 4.2 g/l (l-methionine)     phenylalanine 5.9 g/l (l-phenylalanine)       proline 5.1 g/l (l-proline)   serine 3.4 g/l (l-serine)         threonine 4.2 g/l (l-threonine)       tryptophan 1.4 g/l (l-tryptophan)   tyrosine 0.17 g/l (l-tyrosine) valine 5.5 g/l (l-valine)       excipient: glacial acetic acid water for injection - intravenous supply of amino acids to patients with moderately increased requirements who are unable to receive sufficient amounts of protein enterally

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - alanine 16 g/l;  ;  ;  ; arginine 11.3 g/l (l-arginine);  ;  ; aspartic acid 3.4 g/l (l-aspartic acid);  ;  ; cysteine 560 mg/l (l-cysteine); glutamic acid 5.6 g/l (l-glutamic acid);  ;  ; glycine 7.9 g/l (as aminoacetic acid);  ;  ;  ; histidine 6.8 g/l (l-histidine);  ;  ;  ; isoleucine 5.6 g/l (l-isoleucine);  ;  ;  ; leucine 7.9 g/l (l-leucine);  ;  ;  ; lysine acetate 12.7 g/l equivalent to 6 g/l lysine a;  ;  ; methionine 5.6 g/l (l-methionine);  ;  ; phenylalanine 7.9 g/l (l-phenylalanine);  ;  ;  ; proline 6.8 g/l (l-proline);  ; serine 4.5 g/l (l-serine);  ;  ;  ;  ; threonine 5.6 g/l (l-threonine);  ;  ;  ; tryptophan 1.9 g/l (l-tryptophan);  ; tyrosine 230 mg/l (l-tyrosine); valine 7.3 g/l (l-valine);  ;  ;   - solution for infusion - active: alanine 16 g/l       arginine 11.3 g/l (l-arginine)     aspartic acid 3.4 g/l (l-aspartic acid)     cysteine 560 mg/l (l-cysteine) glutamic acid 5.6 g/l (l-glutamic acid)     glycine 7.9 g/l (as aminoacetic acid)       histidine 6.8 g/l (l-histidine)       isoleucine 5.6 g/l (l-isoleucine)       leucine 7.9 g/l (l-leucine)       lysine acetate 12.7 g/l equivalent to 6 g/l lysine a     methionine 5.6 g/l (l-methionine)     phenylalanine 7.9 g/l (l-phenylalanine)       proline 6.8 g/l (l-proline)   serine 4.5 g/l (l-serine)         threonine 5.6 g/l (l-threonine)       tryptophan 1.9 g/l (l-tryptophan)   tyrosine 230 mg/l (l-tyrosine) valine 7.3 g/l (l-valine)       excipient: glacial acetic acid water for injection - intravenous supply of amino acids to patients with highly increased requirement who are unable to receive sufficient amounts of protein enterally. vamin 18 is also indicated where there is need to control the total amount of fluid being given to a patient. vamin 18 has been shown to reduce nitrogen loss in patients with major burns without sepsis.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - alanine, quantity: 14 g/l; arginine, quantity: 12 g/l; glycine, quantity: 11 g/l; histidine, quantity: 3 g/l; isoleucine, quantity: 5 g/l; leucine, quantity: 7.4 g/l; lysine acetate, quantity: 9.31 g/l (equivalent: lysine, qty 6.6 g/l); methionine, quantity: 4.3 g/l; phenylalanine, quantity: 5.1 g/l; proline, quantity: 11.2 g/l; serine, quantity: 6.5 g/l; taurine, quantity: 1 g/l; threonine, quantity: 4.4 g/l; tryptophan, quantity: 2 g/l; tyrosine, quantity: 400 mg/l; valine, quantity: 6.2 g/l - injection, solution - excipient ingredients: glacial acetic acid; water for injections - to supply amino acids as part of a composite admixture of total parenteral nutrition.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - alanine, quantity: 14 g/l; arginine, quantity: 12 g/l; glycine, quantity: 11 g/l; histidine, quantity: 3 g/l; isoleucine, quantity: 5 g/l; leucine, quantity: 7.4 g/l; lysine acetate, quantity: 9.31 g/l (equivalent: lysine, qty 6.6 g/l); methionine, quantity: 4.3 g/l; phenylalanine, quantity: 5.1 g/l; proline, quantity: 11.2 g/l; serine, quantity: 6.5 g/l; taurine, quantity: 1 g/l; threonine, quantity: 4.4 g/l; tryptophan, quantity: 2 g/l; tyrosine, quantity: 400 mg/l; valine, quantity: 6.2 g/l - injection, solution - excipient ingredients: glacial acetic acid; water for injections - to supply amino acids as part of a composite admixture of total parenteral nutrition.

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

lamberts healthcare ltd - dl-phenylalanine - oral capsule - 500mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

quest vitamins ltd - l-phenylalanine - oral capsule - 500mg

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - alanine,arginine,aspartic acid,calcium chloride dihydrate,glucose monohydrate,glutamic acid,glycine,histidine,isoleucine,leucine,lysine hydrochloride,magnesium sulfate heptahydrate,methionine,phenylalanine,potassium chloride,proline,serine,sodium acetate trihydrate,sodium glycerophosphate,soya oil,threonine,tryptophan,tyrosine,valine -

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - dl-phenylalanine - oral capsule - 500mg